Skip to main content

BARCLAYS PLC

Position in CHRS — Coherus Oncology, Inc.

CIK 312069 LONDON, X0

Position in CHRS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$281,599
-$48,748 QoQ
Shares Held
201,143
+2.9% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in CHRS Over Time

Shares Held

Position Value (USD)

Derivatives in CHRS

reported options exposure · as of Mar 31, 2024
CallValue
$119,261
CallShares
49,900
PutValue
$119,261
PutShares
49,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. CHRS ranks #204 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CHRS

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $281,599 201,143
2026-03-31 $330,347 195,473
2025-12-31 $490,713 345,573
2025-09-30 $480,834 293,192
2025-06-30 $217,611 297,692
2025-03-31 $186,408 230,990
2024-12-31 $414,263 300,192
2024-09-30 $2,564,956 2,466,305
2024-06-30 $3,789,600 2,190,521
2024-03-31 $119,261 49,900
2024-03-31 $119,261 49,900
2024-03-31 $4,936,187 2,065,351
2023-12-31 $11,603,034 3,484,395
2023-09-30 $8,884,582 2,375,557
2023-06-30 $316,462 74,113
2023-03-31 $1,289,449 188,516
2022-12-31 $2,368,127 299,006
2022-09-30 $1,968,166 204,804
2022-06-30 $306,657 42,356
2022-03-31 $703,077 54,460
2021-12-31 $1,543,172 96,690
2021-09-30 $2,124,823 132,223
2021-06-30 $1,486,254 107,466
2021-03-31 $2,170,812 148,584
2020-12-31 $11,175,617 643,016
2020-09-30 $6,259,570 341,307
2020-06-30 $5,088,545 284,913
2020-03-31 $6,633,460 408,968